Atropine is an alkaloid originally synthesized from Atropa belladonna. It is a racemic mixture of d-and l-hyoscyamine, of which only l-hyoscyamine is pharmacologically active. Atropine is generally available as a sulfate salt and can be administered by intravenous, subcutaneous, intramuscular, intraosseous, endotracheal and ophthalmic methods. Oral atropine ...
The intravenous, intramuscular, subcutaneous, intraosseous and endotracheal use of atropine is indicated for the temporary blockade of severe or life-threatening muscarinic effects. The intramuscular use of atropine in the form of a pen injector is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having cholinesterase act...
Shanghai Eye Disease Prevention and Treatment Center, Shanghai, China
Poison Control Center of Ain-Shams University hospitals, Cairo, Abbasya, Egypt
University of California San Diego, La Jolla, California, United States
University Hospital Linköping, Linköping, Östergötland, Sweden
Shanghai General Hospital, Shanghai, China
Shanghai Eye Disease Prevention & Treatment Center, Shanghai, Shanghai, China
Shanghai Ninth People's Hospital, Shanghai, China
The fifth Qingdao people's hospital, Qingdao, Shandong, China
Colorado State University, Fort Collins, Colorado, United States
Mansoura University Hospital, Mansoura, Dakahlia, Egypt
Centre for Living (Glasgow Caledonian University), Glasgow, United Kingdom
Anglia Ruskin University Eye Clinic, Cambridge, United Kingdom
Northern Ireland Clinical Research, Belfast, United Kingdom
Dr. BishnuPokharel, Dharān Bāzār, Sunsari, Nepal
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.